# Amneal Pharmaceuticals, LLC (NASDAQ: AMRX), Piscataway, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/amneal-pharmaceuticals-llc/40df6978-669a-4898-b381-a43f7fb4d40a

> Inspection records and compliance data for Amneal Pharmaceuticals, LLC in Piscataway, New Jersey. 10 FDA inspections on record, 1 Form 483, last inspected April 30, 2026. Publicly traded as NASDAQ: AMRX.

---

## Details

- Name: Amneal Pharmaceuticals, LLC
- FEI Number: 3008861605
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: 1 New England Ave
- City: Piscataway
- State: New Jersey
- Zip Code: 08854
- Country Name: United States
- Address: 1 New England Ave, Piscataway, New Jersey 08854, United States
- Country: United States

## Stock

- Stock ticker: AMRX
- Exchange: NASDAQ
- Share price: $21.70
- Market cap: $7.6B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1309420 - Amneal Pharmaceuticals, LLC - 2026-04-30 — source: FDA, date: April 30, 2026
- FDA Inspection 1256805 - Amneal Pharmaceuticals, LLC - 2025-03-28 — source: FDA, date: March 28, 2025
- [FDA Inspection 1256805 - Amneal Pharmaceuticals, LLC - 2025-03-28](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/a5536a0b-4d17-443a-8dbf-ffff75e7eb54) — classification: No Action Indicated (NAI), source: FDA, date: March 28, 2025
- FDA Inspection 1226102 - Amneal Pharmaceuticals, LLC - 2023-11-21 — classification: No Action Indicated (NAI), source: FDA, date: November 21, 2023
- [483 - Amneal Pharmaceuticals, LLC - 2022-02-10](https://www.keypedia.com/records/483/amneal-pharmaceuticals-llc/1c7d1f79-382c-41a7-9661-7cb95f860d68) — source: FDA, date: February 10, 2022
- FDA Inspection 1162045 - Amneal Pharmaceuticals, LLC - 2022-02-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2022
- FDA Inspection 1075997 - Amneal Pharmaceuticals, LLC - 2018-10-19 — classification: No Action Indicated (NAI), source: FDA, date: October 19, 2018
- [FDA Inspection 1047538 - Amneal Pharmaceuticals, LLC - 2018-04-06](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/eb66987b-3a43-4b7a-8549-00b1f52cb138) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 6, 2018
- FDA Inspection 1004069 - Amneal Pharmaceuticals, LLC - 2017-03-20 — source: FDA, date: March 20, 2017
- FDA Inspection 967059 - Amneal Pharmaceuticals, LLC - 2016-02-19 — classification: No Action Indicated (NAI), source: FDA, date: February 19, 2016
- FDA Inspection 900737 - Amneal Pharmaceuticals, LLC - 2014-10-23 — classification: No Action Indicated (NAI), source: FDA, date: October 23, 2014

## Related Companies

- [Cosette Pharmaceuticals, Inc.](https://www.keypedia.com/companies/cosette-pharmaceuticals-inc/8c3e01d0-f022-4434-8a43-729e36808be4)
- [RiconPharma LLC](https://www.keypedia.com/companies/riconpharma-llc/419021d0-2e97-46b7-977f-1df932afc40b)
- [Sumika Chemical Analysis Service, Ltd.](https://www.keypedia.com/companies/sumika-chemical-analysis-service-ltd/075ab6c9-b05d-47d0-8d9a-0aa4807153a6)
- [Sitec Labs Limited](https://www.keypedia.com/companies/sitec-labs-limited/5ad3197e-7fdd-4d37-b539-3399da5eeeac)
- [Micra Biotechnologies, Inc.](https://www.keypedia.com/companies/micra-biotechnologies-inc/11f16777-7d84-418d-ab67-21398fe9a01d)
- [Atlantic Analytical Laboratories LLC](https://www.keypedia.com/companies/atlantic-analytical-laboratories-llc/61c09a95-e231-47e5-8f79-0cc413d390f6)
- [Biochem Laboratories, Inc.](https://www.keypedia.com/companies/biochem-laboratories-inc/79d2c426-5ad0-4d7f-998a-c53ba9a651a1)
- [TPM Laboratories, Inc.](https://www.keypedia.com/companies/tpm-laboratories-inc/e231f87f-a048-4f6d-919c-85deec3c86fa)
- [Omega Biological Laboratories Inc.](https://www.keypedia.com/companies/omega-biological-laboratories-inc/20fd4f57-0cca-4da6-8bc5-7ea616d0a0d1)
- [Solvias USA, LLC](https://www.keypedia.com/companies/solvias-usa-llc/57917fd7-144e-405d-9894-45bf9bb07971)

## Related Officers

- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [Program Division Director/District Director](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)
